ideasIdea
Community-tailored HPV vaccine confidence campaigns with school-based delivery
The HPV vaccine prevents most cervical cancer, but false safety claims have cut uptake in several countries. Rebuild confidence locally and deliver the vaccine in schools.
HPV vaccination collapsed in Japan after unfounded safety concerns and has stalled in parts of Europe and the US; countries with school-based programmes and sustained trusted messaging (Australia, Scotland, Rwanda) achieve high coverage and are seeing dramatic falls in cervical disease. The proposal is a programme combining school-based single-dose delivery, community-specific confidence work through trusted messengers, and rapid response to local scares, with coverage tracked at district level.
Hypothesis
Tailored confidence campaigns with school delivery raise coverage above 80% in low-uptake districts within three years.
Rationale
Coverage differences between neighbouring countries with the same vaccine show that delivery model and trust, not biology, determine uptake.
What would test it
Cluster-randomised campaign rollout across low-uptake districts with coverage as the primary endpoint.
Maturity
being tested at scale
Who has to act
policy
Cost to try
Medium ($1M to $50M)
Years to first evidence
3
Bottlenecks it attacks
- Misinformation and unproven therapies · Patients are sold unproven treatments and frightened away from proven ones.
- Prevention we already have is not deployed · Around four in ten cancers are preventable with tools we already own: vaccines, tobacco control, weight, alcohol, sun and infection control.